In connection with its monitoring of Laboratory  performance, WADA  may direct Further Analysis  of a Sample which has resulted in a Code Article  2.1 anti-doping rule violation charge without consent of the Athlete  or approval from a hearing body as provided in Code  Article  6.5, provided that the analytical result from that Further Analysis  cannot be used against the Athlete  (for example, re -analysis of Samples which a Laboratory     ISL – January 2021 Page 40 of 160 has reported as Adverse Analytical Findings  when the Laboratory  has been determin ed to have reported False Adverse Analytical Findings  using the same Analytical Method ).